Skip to main content

Advertisement

SpringerLink
Log in

Oncomodulation by human cytomegalovirus: evidence becomes stronger

  • Mini Review
  • Published:
Medical Microbiology and Immunology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

References

  1. Michaelis M, Doerr HW, Cinatl J Jr The story of human cytomegalovirus and cancer: increasing evidence and open questions. Neoplasia (in press)

  2. Ho M (2008) The history of cytomegalovirus and its diseases. Med Microbiol Immunol (Berl) 197:65–73. doi:10.1007/s00430-007-0066-x

    Article  Google Scholar 

  3. Besold K, Plachter B (2008) Recombinant viruses as tools to study human cytomegalovirus immune modulation. Med Microbiol Immunol (Berl) 197:215–222. doi:10.1007/s00430-008-0083-4

    Article  Google Scholar 

  4. Böhm V, Podlech J, Thomas D, Deegen P, Pahl-Seibert MF, Lemmermann NA, Grzimek NK, Oehrlein-Karpi SA, Reddehase MJ, Holtappels R (2008) Epitope-specific in vivo protection against cytomegalovirus disease by CD8 T cells in the murine model of preemptive immunotherapy. Med Microbiol Immunol (Berl) 197:135–144. doi:10.1007/s00430-008-0092-3

    Article  Google Scholar 

  5. Busche A, Angulo A, Kay-Jackson P, Ghazal P, Messerle M (2008) Phenotypes of major immediate-early gene mutants of mouse cytomegalovirus. Med Microbiol Immunol (Berl) 197:233–240. doi:10.1007/s00430-008-0076-3

    Article  Google Scholar 

  6. Campbell AE, Cavanaugh VJ, Slater JS (2008) The salivary glands as a privileged site of cytomegalovirus immune evasion and persistence. Med Microbiol Immunol (Berl) 197:205–213. doi:10.1007/s00430-008-0077-2

    Article  Google Scholar 

  7. Doom CM, Hill AB (2008) MHC class I immune evasion in MCMV infection. Med Microbiol Immunol (Berl) 197:191–204. doi:10.1007/s00430-008-0089-y

    Article  CAS  Google Scholar 

  8. Erlach KC, Böhm V, Knabe M, Deegen P, Reddehase MJ, Podlech J (2008) Activation of hepatic natural killer cells and control of liver-adapted lymphoma in the murine model of cytomegalovirus infection. Med Microbiol Immunol (Berl) 197:167–178. doi:10.1007/s00430-008-0084-3

    Article  CAS  Google Scholar 

  9. Faßbender M, Herter S, Holtappels R, Schild H (2008) Correlation of dendritic cell maturation and the formation of aggregates of poly-ubiquitinated proteins in the cytosol. Med Microbiol Immunol (Berl) 197:185–189. doi:10.1007/s00430-008-0091-4

    Article  Google Scholar 

  10. Grey F, Hook L, Nelson J (2008) The functions of herpesvirus-encoded microRNAs. Med Microbiol Immunol (Berl) 197:261–267. doi:10.1007/s00430-007-0070-1

    Article  CAS  Google Scholar 

  11. Holtappels R, Böhm V, Podlech J, Reddehase MJ (2008) CD8 T-cell-based immunotherapy of cytomegalovirus infection: “proof of concept” provided by the murine model. Med Microbiol Immunol (Berl) 197:125–134. doi:10.1007/s00430-008-0093-2

    Article  Google Scholar 

  12. Lenac T, Arapović J, Traven L, Krmpotić A, Jonjić S (2008) Murine cytomegalovirus regulation of NKG2D ligands. Med Microbiol Immunol (Berl) 197:159–166. doi:10.1007/s00430-008-0080-7

    Article  Google Scholar 

  13. Martin H, Mandron M, Davrinche C (2008) Interplay between human cytomegalovirus and dendritic cells in T cell activation. Med Microbiol Immunol (Berl) 197:179–184. doi:10.1007/s00430-008-0079-0

    Article  Google Scholar 

  14. Maul GG, Negorev D (2008) Differences between mouse and human cytomegalovirus interactions with their respective hosts at immediate early times of the replication cycle. Med Microbiol Immunol (Berl) 197:241–249. doi:10.1007/s00430-008-0078-1

    Article  Google Scholar 

  15. Mersseman V, Böhm V, Holtappels R, Deegen P, Wolfrum U, Plachter B, Reyda S (2008) Refinement of strategies for the development of a human cytomegalovirus dense body vaccine. Med Microbiol Immunol (Berl) 197:97–107. doi:10.1007/s00430-008-0085-2

    Article  CAS  Google Scholar 

  16. Powers C, Früh K (2008) Rhesus CMV: an emerging animal model for human CMV. Med Microbiol Immunol (Berl) 197:109–115. doi:10.1007/s00430-007-0073-y

    Article  Google Scholar 

  17. Sacher T, Jordan S, Mohr CA, Vidy A, Weyn AM, Ruszics Z, Koszinowski UH (2008) Conditional gene expression systems to study herpesvirus biology in vivo. Med Microbiol Immunol (Berl) 197:269–276. doi:10.1007/s00430-008-0086-1

    Article  CAS  Google Scholar 

  18. Seckert CK, Renzaho A, Reddehase MJ, Grzimek NK (2008) Hematopoietic stem cell transplantation with latently infected donors does not transmit virus to immunocompromised recipients in the murine model of cytomegalovirus infection. Med Microbiol Immunol (Berl) 197:251–259. doi:10.1007/s00430-008-0094-1

    Article  Google Scholar 

  19. Stinski MF, Isomura H (2008) Role of the cytomegalovirus major immediate early enhancer in acute infection and reactivation from latency. Med Microbiol Immunol (Berl) 197:223–231. doi:10.1007/s00430-007-0069-7

    Article  Google Scholar 

  20. von Müller L, Mertens T (2008) Human cytomegalovirus infection and antiviral immunity in septic patients without canonical immunosuppression. Med Microbiol Immunol (Berl) 197:75–82. doi:10.1007/s00430-008-0087-0

    Article  Google Scholar 

  21. Waisman A, Croxford AL, Demircik F (2008) New tools to study the role of B cells in cytomegalovirus infections. Med Microbiol Immunol (Berl) 197:145–149. doi:10.1007/s00430-008-0088-z

    Article  Google Scholar 

  22. Waller EC, Day E, Sissons JG, Wills MR (2008) Dynamics of T cell memory in human cytomegalovirus infection. Med Microbiol Immunol (Berl) 197:83–96. doi:10.1007/s00430-008-0082-5

    Article  Google Scholar 

  23. Wirtz N, Schader SI, Holtappels R, Simon CO, Lemmermann NA, Reddehase MJ, Podlech J (2008) Polyclonal cytomegalovirus-specific antibodies not only prevent virus dissemination from the portal of entry but also inhibit focal virus spread within target tissues. Med Microbiol Immunol (Berl) 197:151–158. doi:10.1007/s00430-008-0095-0

    Article  CAS  Google Scholar 

  24. Yue Y, Wang Z, Abel K, Li J, Strelow L, Mandarino A, Eberhardt MK, Schmidt KA, Diamond DJ, Barry PA (2008) Evaluation of recombinant modified vaccinia Ankara virus-based rhesus cytomegalovirus vaccines in rhesus macaques. Med Microbiol Immunol (Berl) 197:117–123. doi:10.1007/s00430-008-0074-5

    Article  CAS  Google Scholar 

  25. Su BY, Su CY, Yu SF, Chen CJ (2007) Incidental discovery of high systemic lupus erythematosus disease activity associated with cytomegalovirus viral activity. Med Microbiol Immunol (Berl) 196:165–170. doi:10.1007/s00430-007-0040-7

    Article  Google Scholar 

  26. Cinatl J Jr, Cinatl J, Vogel JU, Rabenau H, Kornhuber B, Doerr HW (1996) Modulatory effects of human cytomegalovirus infection on malignant properties of cancer cells. Intervirology 39:259–269

    PubMed  Google Scholar 

  27. Cobbs CS, Harkins L, Samanta M, Gillespie GY, Bharara S, King PH, Nabors LB, Cobbs CG, Britt WJ (2002) Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 62:3347–3350

    PubMed  CAS  Google Scholar 

  28. Mitchell DA, Xie W, Schmittling R, Learn C, Friedman A, McLendon RE, Sampson JH (2008) Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro oncol 10:10–18. doi:10.1215/15228517-2007-035

    Article  PubMed  Google Scholar 

  29. Söderberg-Nauclér C (2008) HCMV microinfections in inflammatory diseases and cancer. J Clin Virol 41:218–223. doi:10.1016/j.jcv.2007.11.009

    Article  PubMed  Google Scholar 

  30. Scheurer ME, Bondy ML, Aldape KD, Albrecht T, El-Zein R (2008) Detection of human cytomegalovirus in different histological types of gliomas. Acta Neuropathol 116:79–86. doi:10.1007/s00401-008-0359-1

    Article  PubMed  CAS  Google Scholar 

  31. Lau SK, Chen YY, Chen WG, Diamond DJ, Mamelak AN, Zaia JA, Weiss LM (2005) Lack of association of cytomegalovirus with human brain tumors. Mod Pathol 18:838–843. doi:10.1038/modpathol.3800352

    Article  PubMed  CAS  Google Scholar 

  32. Poltermann S, Schlehofer B, Steindorf K, Schnitzler P, Geletneky K, Schlehofer JR (2006) Lack of association of herpesviruses with brain tumors. J Neurovirol 12:90–99. doi:10.1080/13550280600654573

    Article  PubMed  CAS  Google Scholar 

  33. Sabatier J, Uro-Coste E, Pommepuy I, Labrousse F, Allart S, Trémoulet M, Delisle MB, Brousset P (2005) Detection of human cytomegalovirus genome and gene products in central nervous system tumours. Br J Cancer 92:747–750. doi:10.1038/sj.bjc.6602339

    Article  PubMed  CAS  Google Scholar 

  34. Prins RM, Cloughesy TF, Liau LM (2008) Cytomegalovirus immunity after vaccination with autologous glioblastoma lysate. N Engl J Med 359:539–541. doi:10.1056/NEJMc0804818

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institut für Medizinische Virologie, Klinikum der Johann Wolfgang Goethe-Universität, Paul Ehrlich-Str. 40, 60596, Frankfurt am Main, Germany

    Martin Michaelis, Hans Wilhelm Doerr & Jindrich Cinatl Jr

Authors
  1. Martin Michaelis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Hans Wilhelm Doerr
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jindrich Cinatl Jr
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jindrich Cinatl Jr.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Michaelis, M., Doerr, H.W. & Cinatl, J. Oncomodulation by human cytomegalovirus: evidence becomes stronger. Med Microbiol Immunol 198, 79–81 (2009). https://doi.org/10.1007/s00430-009-0107-8

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00430-009-0107-8

Keywords

Search

Navigation